181 related articles for article (PubMed ID: 37818374)
21. Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins.
Aarsund M; Nyman TA; Stensland ME; Wu Y; Inngjerdingen M
Front Immunol; 2022; 13():977353. PubMed ID: 36189227
[TBL] [Abstract][Full Text] [Related]
22. Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations.
Nathani A; Sun L; Khan I; Aare M; Bagde A; Li Y; Singh M
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258094
[TBL] [Abstract][Full Text] [Related]
23. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells.
Del Vecchio F; Martinez-Rodriguez V; Schukking M; Cocks A; Broseghini E; Fabbri M
J Extracell Vesicles; 2021 Apr; 10(6):e12075. PubMed ID: 33815694
[TBL] [Abstract][Full Text] [Related]
24. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
Fabbri M
Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
[TBL] [Abstract][Full Text] [Related]
25. Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy.
Wu J; Wu D; Wu G; Bei HP; Li Z; Xu H; Wang Y; Wu D; Liu H; Shi S; Zhao C; Xu Y; He Y; Li J; Wang C; Zhao X; Wang S
Biofabrication; 2022 Aug; 14(4):. PubMed ID: 35793612
[TBL] [Abstract][Full Text] [Related]
26. Cytokine-enhanced cytolytic activity of exosomes from NK Cells.
Enomoto Y; Li P; Jenkins LM; Anastasakis D; Lyons GC; Hafner M; Leonard WJ
Cancer Gene Ther; 2022 Jun; 29(6):734-749. PubMed ID: 34316033
[TBL] [Abstract][Full Text] [Related]
27. High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.
Müller S; Bexte T; Gebel V; Kalensee F; Stolzenberg E; Hartmann J; Koehl U; Schambach A; Wels WS; Modlich U; Ullrich E
Front Immunol; 2019; 10():3123. PubMed ID: 32117200
[TBL] [Abstract][Full Text] [Related]
28. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
Rafei H; Daher M; Rezvani K
Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
[TBL] [Abstract][Full Text] [Related]
29. Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.
Karvouni M; Vidal-Manrique M; Susek KH; Hussain A; Gilljam M; Zhang Y; Gray JD; Lund J; Kaufmann G; Ljunggren HG; Ji H; Lundqvist A; Wagner AK; Guo W; Alici E
Cytotherapy; 2023 Jul; 25(7):763-772. PubMed ID: 37055320
[TBL] [Abstract][Full Text] [Related]
30. T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.
Morton LT; Wachsmann TLA; Meeuwsen MH; Wouters AK; Remst DFG; van Loenen MM; Falkenburg JHF; Heemskerk MHM
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288464
[TBL] [Abstract][Full Text] [Related]
31. Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses.
Dosil SG; Lopez-Cobo S; Rodriguez-Galan A; Fernandez-Delgado I; Ramirez-Huesca M; Milan-Rois P; Castellanos M; Somoza A; Gómez MJ; Reyburn HT; Vales-Gomez M; Sánchez Madrid F; Fernandez-Messina L
Elife; 2022 Jul; 11():. PubMed ID: 35904241
[TBL] [Abstract][Full Text] [Related]
32. PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.
Guo Y; Feng X; Jiang Y; Shi X; Xing X; Liu X; Li N; Fadeel B; Zheng C
Oncotarget; 2016 Jul; 7(30):48360-48374. PubMed ID: 27356741
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of cellular cytotoxicity mediated by a cloned human natural killer cell line.
Mahle NH; Radcliff G; Sevilla CL; Kornbluth J; Callewaert DM
Immunobiology; 1989 Jun; 179(2-3):230-43. PubMed ID: 2793204
[TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
35. Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.
Motais B; Charvátová S; Walek Z; Hrdinka M; Smolarczyk R; Cichoń T; Czapla J; Giebel S; Šimíček M; Jelínek T; Ševčíková T; Sobotka J; Kořístek Z; Hájek R; Bagó JR
Cells; 2021 Apr; 10(5):. PubMed ID: 33919155
[TBL] [Abstract][Full Text] [Related]
36. Cancer extracellular vesicles as novel regulators of NK cell response.
Soriani A; Vulpis E; Cuollo L; Santoni A; Zingoni A
Cytokine Growth Factor Rev; 2020 Feb; 51():19-26. PubMed ID: 31837917
[TBL] [Abstract][Full Text] [Related]
37. Potential of NK cells in multiple Myeloma therapy.
Khan AM; Devarakonda S; Bumma N; Chaudhry M; Benson DM
Expert Rev Hematol; 2019 Jun; 12(6):425-435. PubMed ID: 31070067
[No Abstract] [Full Text] [Related]
38. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.
Federici C; Shahaj E; Cecchetti S; Camerini S; Casella M; Iessi E; Camisaschi C; Paolino G; Calvieri S; Ferro S; Cova A; Squarcina P; Bertuccini L; Iosi F; Huber V; Lugini L
Front Immunol; 2020; 11():262. PubMed ID: 32231660
[TBL] [Abstract][Full Text] [Related]
39. NK Cell Regulatory Property is Involved in the Protective Role of MSC-Derived Extracellular Vesicles in Renal Ischemic Reperfusion Injury.
Zou X; Gu D; Zhang G; Zhong L; Cheng Z; Liu G; Zhu Y
Hum Gene Ther; 2016 Nov; 27(11):926-935. PubMed ID: 27510907
[TBL] [Abstract][Full Text] [Related]
40. Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
Harshman SW; Canella A; Ciarlariello PD; Agarwal K; Branson OE; Rocci A; Cordero H; Phelps MA; Hade EM; Dubovsky JA; Palumbo A; Rosko A; Byrd JC; Hofmeister CC; Benson DM; Paulaitis ME; Freitas MA; Pichiorri F
J Proteomics; 2016 Mar; 136():89-98. PubMed ID: 26775013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
